Clinical Trials on Prader-Willi Syndrome in United Kingdom

Total 14759 results

University of Florida
National Institutes of Health (NIH)

Completed

Oxytocin Trial in Prader-Willi Syndrome

Prader Willi Syndrome

United States
Duke University
Canadian Institutes of Health Research (CIHR); National Institutes of Health... and other collaborators

Completed

Macronutrient Regulation of Ghrelin and Peptide YY

Obesity | Prader Willi Syndrome

United States
Duke University
Foundation for Prader-Willi Research

Completed

Prader-Willi Syndrome Macronutrient Study

Childhood Obesity | Prader Willi Syndrome | Syndromic Obesity

United States, Canada
California State University, Fullerton
University of Florida

Unknown

Family-based Intervention for Youth With Prader-Willi Syndrome: The Active Play at Home Study (APAH)

Childhood Obesity | Prader Willi Syndrome

United States
Weill Medical College of Cornell University
National Institutes of Health (NIH); PWSAUSA

Terminated

Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome (PWS)

Prader-willi Syndrome

United States
University of Florida
Foundation for Prader-Willi Research

Completed

Hypoglycemia in Prader-Willi Syndrome

Hypoglycemia | Prader Willi Syndrome

United States
Ferring Pharmaceuticals

Completed

Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome

Hyperphagia in Prader-Willi Syndrome

United States
Nationwide Children's Hospital

Completed

Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome

Adrenal Insufficiency | Prader Willi Syndrome

United States
ACADIA Pharmaceuticals Inc.

Recruiting

Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

Hyperphagia in Prader-Willi Syndrome

United States, Canada
University of South Florida
Johns Hopkins All Children's Hospital

Completed

Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project

Obsessive-compulsive Disorder | Prader Willi Syndrome

United States
University Hospital, Toulouse
European Society for Paediatric Endocrinology

Completed

PWS European Blood Bank for Infants and Controls From 0 to 48 Months

Prader-Willi Syndrome

Sweden, Belgium, France, Germany, Netherlands, United Kingdom
Soleno Therapeutics, Inc.

Completed

A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome

Prader-Willi Syndrome

United States, United Kingdom
Soleno Therapeutics, Inc.

Active, not recruiting

Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome

Prader-Willi Syndrome

United States, United Kingdom
Soleno Therapeutics, Inc.

Completed

Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period

Prader-Willi Syndrome

United States, United Kingdom
Millendo Therapeutics SAS

Terminated

Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome (ZEPHYR)

Hyperphagia | Prader-Willi Syndrome

United States, Belgium, Spain, France, Italy, United Kingdom, Australia, Netherlands
Brigham and Women's Hospital
Foundation for Prader-Willi Research

Recruiting

Cerebellar TMS and Satiety in Prader-Willi Syndrome

Prader-Willi Syndrome

United States
Saniona

Withdrawn

Study of Tesomet With Open-label Extension in Subjects With Prader-Willi Syndrome (PWS)

Prader-Willi Syndrome

United States
Foundation for Prader-Willi Research
Prader-Willi Syndrome Association USA; Foundation for Prader-Willi Research... and other collaborators

Completed

Natural History Study of Serious Medical Events in PWS (PATH for PWS)

Prader-Willi Syndrome

United States
University of Florida
Prader-Willi Syndrome Association

Completed

Intranasal Oxytocin for Infants With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
Essentialis, Inc.

Completed

Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
Aardvark Therapeutics, Inc.
Children's Hospital Colorado; Stanford University

Recruiting

A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
Children's Mercy Hospital Kansas City

Completed

Growth Hormone Use in Adults With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
Foundation for Prader-Willi Research
RTI International

Recruiting

A Clinical Evaluation of Non-Invasive Vagus Nerve Stimulation for Temper Outbursts in People With PWS (VNS4PWS)

Prader-Willi Syndrome

United States
University of Wisconsin, Madison
Ultragenyx Pharmaceutical Inc

Completed

Development of a Newborn Screening Assay for Angelman Syndrome and Prader-Willi Syndrome

Prader-Willi Syndrome | Angelman Syndrome

United States
GLWL Research Inc.

Completed

A Study of GLWL-01 in Patients With Prader-Willi Syndrome

Prader-Willi Syndrome

United States, Canada
Children's Hospital Los Angeles

Completed

Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
Eunice Kennedy Shriver National Institute of Child...

Completed

Treatment of Self-Injurious Behavior in Individuals With Prader-Willi Syndrome

Self-Injurious Behavior | Prader-Willi Syndrome

United States
Radius Pharmaceuticals, Inc.

Terminated

A Study to Assess RAD011 (Cannabidiol Oral Solution) for the Treatment of Participants With Prader-Willi Syndrome (SCOUT-015)

Prader-Willi Syndrome

United States
ConSynance Therapeutics

Completed

A Pharmacokinetic and Safety Study of CSTI-500 in Subjects With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
Radius Pharmaceuticals, Inc.
Benuvia Therapeutics Inc.

Terminated

A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Participants With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
Soleno Therapeutics, Inc.
Casimir Trials

Unknown

PWS Outcomes Assessment Study

Prader-Willi Syndrome

United States
Montefiore Medical Center
Jazz Pharmaceuticals; Foundation for Prader-Willi Research

Active, not recruiting

CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)

Prader-Willi Syndrome

United States
Duke University
Novartis; National Institutes of Health (NIH); National Center for Research Resources...

Terminated

Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)

Prader-Willi Syndrome

United States
Rutgers, The State University of New Jersey

Completed

Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi Syndrome (PWSGUT)

Obesity | Prader-Willi Syndrome

United States
Zafgen, Inc.

Terminated

Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome (bestPWS)

Obesity | Prader-Willi Syndrome

United States
Gedeon Richter Plc.

Recruiting

Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome

Prader-Willi Syndrome

United States, Spain, Czechia, Italy, France
University of Kansas Medical Center
Harvard Medical School (HMS and HSDM); Foundation for Prader-Willi Research; Prader-Willi...

Completed

Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation-induced Modulation of Hyperphagia in Prader-Willi Syndrome

Hyperphagia | Prader-Willi Syndrome

United States
University of Florida
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Characteristics of Prader-Willi Syndrome and Early-onset Morbid Obesity

Obesity | Prader-Willi Syndrome

United States
Levo Therapeutics, Inc.

Completed

Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome (CARE-PWS)

Prader-Willi Syndrome

United States, Canada, Australia
Rhythm Pharmaceuticals, Inc.

Completed

Phase 2 Trial to Evaluate Safety and Efficacy of Setmelanotide (RM-493) in Obese Participants With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
Harmony Biosciences, LLC

Recruiting

A Study of Pitolisant in Patients With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
Radius Pharmaceuticals, Inc.

Terminated

Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
Zafgen, Inc.

Completed

An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Prader-Willi Syndrome

Obesity | Prader-Willi Syndrome | Over-weight

United States
NYU Langone Health
Winthrop University Hospital

Withdrawn

Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injuries Behavior Associated With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
Neuren Pharmaceuticals Limited

Recruiting

An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001) (PWS-001)

Prader-Willi Syndrome

United States
Montefiore Medical Center

Recruiting

Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome

Hyperphagia | Prader-Willi Syndrome

United States
Montefiore Medical Center
Foundation for Prader-Willi Research

Completed

Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome (OXT-PWS)

Hyperphagia | Prader-Willi Syndrome

United States
Harmony Biosciences, LLC

Active, not recruiting

A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension

Prader-Willi Syndrome

United States
Indiana University
Integrated Listening Systems

Terminated

Home-based SSP on Individuals With PWS

Prader-Willi Syndrome

United States
Novo Nordisk A/S

Completed

Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome

Obesity | Metabolism and Nutrition Disorder

France, United States, Turkey, Italy, Australia, New Zealand, Canada, Netherlands

Clinical Trials on Prader-Willi Syndrome in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations